title: Paradoxical motor syndrome following a switch from atypical neuroleptics to aripiprazole.
authors.forename: Beryl
authors.initials: B
authors.lastname: Koener
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Hermans
authors.forename: Hermans
authors.initials: H
authors.lastname: Emmanuel
authors.forename: Jean-Marie
authors.initials: JM
authors.lastname: Maloteaux
authors.forename: Anne
authors.initials: A
authors.lastname: Jean-Jean
authors.forename: Eric Louis
authors.initials: EL
authors.lastname: Constant
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use*; D000068180:Aripiprazole; D001714:Bipolar Disorder / Q000188:drug therapy* / Q000378:metabolism / Q000523:psychology; D065127:Dopamine D2 Receptor Antagonists; D005260:Female; D006801:Humans; D008875:Middle Aged; D020734:Parkinsonian Disorders / Q000139:chemically induced*; D010879:Piperazines / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D015363:Quinolones / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D017448:Receptors, Dopamine D2 / Q000819:agonists / Q000187:drug effects
chemical_list: D014150:Antipsychotic Agents; D065127:Dopamine D2 Receptor Antagonists; D010879:Piperazines; D015363:Quinolones; D017448:Receptors, Dopamine D2; D000068180:Aripiprazole